David Hackos

David Hackos is a seasoned biopharmaceutical professional with extensive experience in ion channel research and drug discovery. As Vice President of Discovery at SiteOne Therapeutics since September 2024, Hackos leads initiatives focused on therapeutics for hypersensitivity disorders. Previously, Hackos served as a Distinguished Scientist at Genentech from June 2009 to September 2024, directing a pain group that targeted various ion channels. Prior roles included leadership positions at Roche Pharmaceuticals, Renovis, and a postdoctoral fellowship at the National Institutes of Health. Hackos holds a Ph.D. in Biophysics from the University of California, San Francisco, and a B.A. in Physics from The Johns Hopkins University.